CHAL Newsletters
Upcoming Meetings Submit an Abstract
Abstracts Webinars
Executive Committee Mission About the ACS Join CHAL

258th Meeting Highlights

ORLANDO, FL | March 31 - April 3, 2019

Featured
Trade secret strategies for pharmaceutical innovations

Shana K. Cyr, Finnegan, Reston, VA
Megan Meyers, Finnegan, Atlanta, GA

Post-grant review in Hatch-Waxman litigation

David Weingarten, Finnegan Henderson, Atlanta, GA
Katherine Leonard, Finnegan Henderson, Atlanta, GA

Patent litigation under the Hatch-Waxman Act

Shana K. Cyr, Finnegan, Reston, VA

Patent prosecution and portfolio management in the pharmaceutical industry

David Weingarten, Finnegan Henderson, Atlanta, GA

Beyond the bench: Non-traditional careers in chemistry

James Carver, The Carver Law Firm, LLC, Baton Rouge, LA
Sofia Santos, Finnegan LLP, Boston, MA
Krista E. Bianco, Finnegan LLP, Washington, DC
Katherine Lavoie, The Boston Consulting Group, Boston, MA
Judy Cohen, Particle Sciences Inc., Bethlehem, PA

Post-grant proceedings of bio & pharma patents: A brief overview and analysis of noteworthy cases since implementation of the America Invents Act

Katherine A. Rubino
Caldwell Intellectual Property Law, Boston, MA

Strategies for monetization of patent portfolios in chemical fields

Katherine A. Rubino
Caldwell Intellectual Property Law, Boston, MA

Monitoring Hg emissions from gold shops in Peru: Science vs policy

Adam M. Kiefer
Chemistry Dept., Mercer University, Macon, Georgia, United States

Strengthening your future patent rights in light of recent Federal Circuit court and USPTO decisions

Xavier Pillai
Leydig Voit Mayer Ltd, Chicago, IL

AdobeStock_106351786.jpeg

257th Meeting Highlights

Boston, MA | August 18-22, 2018

Featured
Patent term adjustment in the U.S.

Richard Bone
McDermott Will & Emery LLP, Menlo Park, CA

Patent term extensions and data exclusivity in Australia, New Zealand and South East Asia

Jess Gledhill
FB Rice, Sydney, New South Wales

John Landells
FB Rice, Melbourne, Victoria, Australia

Supplementary protection certificates in the European Union

Isobel Finnie
Haseltine Lake LLP, Bristol, UK

Patent term extension in the U.S.

Kristin Connarn, McDermott
Will & Emery LLP, Boston, MA

Extensions to patent term in the U.S. and worldwide

Richard Bone
McDermott Will & Emery LLP, Menlo Park, CA

Definiteness and the Medicines Co. and Forest Labs. Decisions

Dr. Brian Trinque
Lathrop Gage LLP, Boston MA

Obviousness, the CAFC, and Second Generation Filing Strategies

Dr. Benjamin A. Vaughan and Dr. Nicole Sassu
​​​​​​​Lathrop Gage LLP, Boston MA

What Constitutes an Inventor? A Review of Federal Circuit Case Law

Dr. Andrew Ehle
Lathrop Gage LLP, Boston MA

Pharmaceutical Patent Prosecution Primer

Dr. Brian Trinque
Lathrop Gage LLP

 

AdobeStock_106351786.jpeg

256th Meeting Highlights

New Orleans, LA | March 18-22, 2018

 

AdobeStock_106351786.jpeg

255th Meeting Highlights

Washington, DC | August 20-24, 2017

Featured
Practical Considerations for patent portfolio management

Krista E. Bianco
​​​​​​​Finnegan LLP

Better together? How to avoid common pitfalls in joint ventures

Charles Collins-Chase
Finnegan LLP

Options for protecting your intellectual property and IP trends in renewable energy

Matthew Hlinka
Finnegan LLP

Interplay between patent office postgrant challenges and district court patent infringement cases

Justin J. Hasford
Erin M. Sommers
​​​​​​​Finnegan LLP

Recent developments in post-grant review preceedings

Krista E. Bianco
Kassandra Officer
Finnegan LLP